Dova Pharmaceuticals Inc. - DOVA
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DEUTSCHE BANK AG\ | History | Reduced | 30,729 | 645 | 0.0% | 0.0% | 1 | -263 | -0.85% | Q3 2018 | Dec 21, 2021 |
| MetLife Investment Management, LLC | History | New | 6,038 | 126 | 0.04% | — | 2 | +6,038 | New | Q3 2018 | Jul 13, 2023 |
| Federation des caisses Desjardins du Quebec | History | Closed out | 0 | 0 | — | 0.0% | — | -180 | -100.0% | Q2 2018 | Aug 30, 2024 |